How should I evaluate and manage a patient with a 7‑day history of bilateral shin pain aggravated by jumping, with pending complete blood count, comprehensive metabolic panel, and 25‑hydroxyvitamin D levels?

When to Order CBC, CMP, and Vitamin D Testing in Bilateral Shin Pain

For a patient with 7 days of bilateral shin pain aggravated by jumping, order a complete blood count (CBC), comprehensive metabolic panel (CMP), and 25-hydroxyvitamin D level as part of the initial workup to exclude underlying metabolic, hematologic, and nutritional causes of bone pain.

Clinical Context and Differential Diagnosis

Bilateral shin pain with jumping suggests either mechanical overuse (medial tibial stress syndrome, stress fracture) or an underlying metabolic bone disorder. The 7-day duration is relatively acute, but laboratory evaluation is warranted to identify treatable systemic causes that could impair healing or indicate more serious pathology.

Key Red Flags to Assess

• Pain at rest or night pain (suggests metabolic bone disease, infection, or malignancy rather than mechanical overuse)
• Constitutional symptoms (fever, weight loss, fatigue—consider infection, malignancy, or systemic disease)
• History of minimal trauma fractures (suggests osteomalacia or other metabolic bone disease)
• Risk factors for vitamin D deficiency: limited sun exposure, dark skin, covered clothing, malabsorption, obesity, chronic kidney disease, or medications (anticonvulsants, glucocorticoids) 1

Laboratory Testing Rationale

Complete Blood Count (CBC)

The CBC screens for:

• Anemia that could indicate chronic disease, malabsorption, or bone marrow pathology
• Leukocytosis or leukopenia suggesting infection or systemic inflammatory conditions
• Thrombocytopenia that may accompany hematologic disorders

Evidence supports CBC as part of the metabolic workup for bone stress injury, particularly when evaluating for low energy availability or systemic causes 2.

Comprehensive Metabolic Panel (CMP)

The CMP evaluates:

• Serum calcium and phosphate: Normal levels do NOT exclude metabolic bone disease, as calcium may be maintained through bone mobilization 3
• Alkaline phosphatase: May be elevated in metabolic bone disease, though variable 4, 3
• Renal function: Chronic kidney disease impairs vitamin D activation and is associated with bone disease 5
• Liver function: Severe liver disease decreases 25-hydroxylase activity, impairing vitamin D metabolism 6

25-Hydroxyvitamin D Level

Serum 25(OH)D is the best indicator of vitamin D status 4, 1. Vitamin D deficiency causes:

• Impaired calcium absorption and bone mineralization
• Muscle weakness and increased fall risk
• Delayed fracture healing
• Nonspecific musculoskeletal pain, including leg pain 7

Target levels for bone health:

• Minimum consensus: ≥30 ng/mL (75 nmol/L) 4, 8, 4, 1
• Levels below 20-30 ng/mL require treatment 1, 9

Studies demonstrate a strong association between vitamin D deficiency and leg pain specifically (OR = 7.4) 7, making this test particularly relevant for bilateral shin pain.

When Additional Testing Is Needed

If initial labs reveal abnormalities or clinical suspicion remains high, consider:

• Parathyroid hormone (PTH): Only if calcium is abnormal 3. Primary hyperparathyroidism can cause bone pain and lytic lesions 10
• Iron panel with ferritin: Especially in athletes or if anemia is present 2
• Bone-specific markers: Generally not needed initially unless alkaline phosphatase is elevated 4
• Serologic testing: If constitutional symptoms or rash present (e.g., syphilis can cause bilateral tibia periostitis) 11

Common Pitfalls to Avoid

1. Assuming normal calcium excludes metabolic bone disease: Calcium is often normal in vitamin D deficiency because it's mobilized from bone 3

2. Ordering 1,25-dihydroxyvitamin D instead of 25(OH)D: The active form (1,25[OH]₂D) does NOT reflect vitamin D status and should not be used for screening 8

3. Dismissing vitamin D testing as "not diagnostic": While one study 12 found vitamin D deficiency equally common in controls, this reflects the high population prevalence of deficiency rather than lack of clinical relevance. Treatment is still indicated when deficiency is found 1, 7

4. Delaying imaging: Laboratory tests complement but do not replace appropriate imaging (X-ray, MRI, or bone scan) to evaluate for stress fracture or other structural pathology

Management Based on Results

If Vitamin D Deficiency Found (<30 ng/mL):

• Severe deficiency (<20 ng/mL): Ergocalciferol 50,000 IU weekly for 8 weeks, then recheck 4
• Mild deficiency (20-30 ng/mL): Add 1,000 IU daily vitamin D₃, recheck in 3 months 4
• Maintenance: 800-1,000 IU daily once replete 4
• Higher doses needed (6,000-10,000 IU daily) for obesity, malabsorption, or medications affecting vitamin D metabolism 1

If Calcium or Other Abnormalities Found:

Pursue targeted evaluation based on specific findings (PTH for calcium abnormalities, hematology referral for significant CBC abnormalities, nephrology for renal dysfunction with bone disease).

If All Labs Normal:

Focus on mechanical causes (stress fracture, medial tibial stress syndrome) with appropriate imaging and activity modification. Consider empiric vitamin D supplementation to optimize bone health even if levels are "sufficient" but suboptimal 13.